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Abstract
Higher trait optimism and/or lower cynical hostility are associated with healthier behaviors and lower risk of morbidity and mortality,
yet their association with health care utilization has been understudied. Whether these psychological attitudes are associated with
breast cancer screening behavior is unknown. To assess the association of optimism and cynical hostility with screening
mammography in older women and whether sociodemographic factors acted as mediators of these relationships, we used
Women’s Health Initiative (WHI) observational cohort survey data linked to Medicare claims. The sample includes WHI participants
without history of breast cancer whowere enrolled in Medicare Parts A and B for≥2 years from 2005–2010, and who completedWHI
baseline attitudinal questionnaires (n=48,291). We used survival modeling to examine whether screening frequency varied by
psychological attitudes (measured at study baseline) after adjusting for sociodemographic characteristics, health conditions, and
healthcare-related variables. Psychological attitudes included trait optimism (Life Orientation Test-Revised) and cynical hostility (Cook
Medley subscale), which were self-reported at study baseline. Sociodemographic, health conditions, and healthcare variables were
self-reported at baseline and updated through 2005 as available. Contrary to our hypotheses, repeated events survival models
showed that women with the lowest optimism scores (i.e., more pessimistic tendencies) received 5%more frequent screenings after
complete covariate adjustment (p< .01) compared to themost optimistic group, and showed no association between cynical hostility
and frequency of screening mammograms. Sociodemographic factors did not appear to mediate the relationship between optimism
and screenings. However, higher levels of education and higher levels of income were associated with more frequent screenings
(both p< .01). We also found that results for optimismwere primarily driven by womenwhowere aged 75 or older after January 2009,
when changes to clinical guidelines lead to uncertainty about risks and beneﬁts of screening in this age group. The study
demonstrated that lower optimism, higher education, and higher income were all associated with more frequent screening
mammograms in this sample after repeated events survival modeling and covariate adjustment.
Abbreviations: BMI = body mass index, CES-D = Center for Epidemiologic Studies Depression Scale, CT = clinical trial, FDA =
Food & Drug Administration (U.S.), FFS = fee for service, HCPCS/CPT = Healthcare Common Procedure Coding System/Common
Procedural Terminology System, HR = hazard ratio, LOT-R = Life Orientation Test-Revised, MET = metabolic equivalent, OS =
observational study, SES= socioeconomic status, USPSTF=U.S. Preventive Services Task Force,WHI=Women’s Health Initiative.
Keywords: breast cancer, cynical hostility, optimism, psychological attitudes, screening mammograms
Editor: Phillip Phan.
The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Humans Services through
contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C.
The authors have no conﬂicts of interest to report.
This manuscript was prepared in collaboration with investigators of the WHI and has been reviewed and approved by the Women’s Health Initiative (WHI). The short list
of WHI investigators can be found at https://www.whi.org/researchers/Documents%20%20Write%20a%20Paper/WHI%20Investigator%20Short%20List.pdf
a Health Equity Research Lab, Department of Psychiatry, Cambridge Health Alliance, Cambridge, b Department of Psychiatry, Harvard Medical School, Boston, MA,
c Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, dDepartment of Health Policy and Management, University of Pittsburgh
School of Public Health, e Departments of Medicine and Biostatistics, University of Pittsburgh School of Medicine, f Department of Psychiatry, University of Pittsburgh
School of Medicine, Pittsburgh, PA, gDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, hDepartment of Epidemiology, University of Pittsburgh
Graduate School of Public Health, Pittsburgh, PA, i Department of Quantitative Health Sciences, University of Massachusetts Medical School, j Department of Medicine,
University of Massachusetts Medical School, Worcester, MA, k Department of Public Health Sciences, University of California Davis School of Medicine, Davis, CA,
l Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, mGeriatric Research Education and Clinical Centers (GRECC), Veterans Affairs Tennessee
Valley Healthcare System, Nashville, TN.
∗
Correspondence: Ana M. Progovac, Instructor, Department of Psychiatry, Harvard Medical School; Senior Scientist, Health Equity Research Lab, Cambridge Health
Alliance, 1035 Cambridge Street, Suite 26, Cambridge, MA 02141 (e-mail: aprogovac@cha.harvard.edu).
Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is
permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the
journal.
Medicine (2019) 98:24(e15869)
Received: 22 October 2018 / Received in ﬁnal form: 22 April 2019 / Accepted: 9 May 2019
http://dx.doi.org/10.1097/MD.0000000000015869
Observational Study Medicine®
OPEN
1
1. Introduction
While regular screenings have clear positive implications for
early detection of disease, screening recommendations increas-
ingly weigh the health risks of over-screening as well. Excess
detection of early-stage breast cancers, for example, could
expose women to treatment-related physical and emotional
harms without a clear mortality beneﬁt.[1] Evolving breast
cancer screening guidelines therefore attempt to balance the
potential risks of over-screening with potential beneﬁts,
especially in older women.[2–5] Where evidence is insufﬁcient,
guidelines now urge physicians to weigh their patient’s “values
regarding speciﬁc beneﬁts and harms.”[6] These individualized
considerations are shaped in part by complex interrelated
characteristics including health and socioeconomic status (SES),
access to care, race/ethnicity, health risk perceptions, and
psychological traits.
Whitewomen typically report12%to15%higher screening rates
than Black andHispanic women,[9] andwomen earning125%of
the federal poverty level are half as likely as higher-income peers to
undergo screenings.[10] Health care access and insurance coverage
also impact screening rates[10] independent of race/ethnicity.[5] Yet
even as physicians are now required to incorporate patients’ values
around screenings, there is a gap in understanding how
psychological attitudes inﬂuence screening behavior.
Women with high dispositional optimism (positive future
expectation[11]) or low cynical hostility (mistrust of others[12])
have lower rates of coronary heart disease, cancer-related
mortality, and overall mortality,[8] in part driven by healthier
behaviors.[13–19] Higher optimism has also been associated with
lower risk of re-hospitalization after coronary artery bypass
surgery.[18,20] These psychological attitudes also vary by SES[7]
and race/ethnicity,[8] likely due to differential exposures to stress
and discrimination. High levels of psychological attitudes of
pessimism and cynical hostility, even if inﬂuenced by past
events, may negatively inﬂuence the decision to screen,[7,21]
particularly if a woman is more likely to perceive that the test
may not make a difference (e.g., pessimistic outlook) or that the
healthcare personnel involved in the testing will be disrespectful
or unhelpful (e.g., cynical hostile outlook). Yet to our
knowledge, no data exist about the role of optimism and
cynical hostility with respect to screening mammography in
aging postmenopausal women.
The current analysis seeks to extend existing knowledge about
optimism, cynical hostility, and screening mammography by
linkingdemographic, psychosocial, andhealth-related factors from
WHI participants to Medicare claims data. We examine whether
optimism and cynical hostility are independently correlated with
mammogram screening frequency, hypothesizing that
(1) more optimistic and less cynically hostile women would have
more frequent screenings, and that
(2) sociodemographic factors may mediate this effect.
2. Methods
2.1. Overview
We examined the association between psychological attitudes
(optimism and cynical hostility, measured at study baseline) and
mammogram screening frequency using repeated events survival
analyses, adjusted ﬁrst for age only, then additional health and
healthcare related factors, and then additionally for sociodemo-
graphic covariates. Survival models are appropriate for analyzing
data where the outcome is the time to a speciﬁc event of interest
(i.e., screening mammography), and in this case, the event can
happen repeatedly. These models account for multiple screenings
per person, and therefore for variation both within and between
subjects.
2.2. Study population
Between1994and1998, theWHI,[22] the largest longitudinal study
of post-menopausal U.S. women, recruited 161,808 women from
diverse racial/ethnic and socioeconomic backgrounds, ages 50 to
79, from 24 states and the District of Columbia. Eligible women
participated in either the clinical trial (CT; n=68,132) or the
observational study (OS;n=93,676).[22]Exclusion criteria relevant
to the current study include: substance abuse (except smoking or
alcohol), mental illness (severe depression, dementia), life expec-
tancyunder3 years, other randomized trialparticipation, andplans
to move within 3 years.[22] Our analysis includes CT or OS
participants still enrolled in the WHI on January 1, 2005
(n=115,399) who had linked Medicare claims (n=102,855),
had baseline scores for optimism and cynical hostility, were
continuously enrolled in fee-for-service (FFS)Medicare Parts A and
B for at least 2 yearsduring2005 to2010, andwere free frombreast
cancer before 2005 (ﬁnal n=48,291, see Fig. 1). Medicare Parts A
and B provide coverage for inpatient and outpatient care,
respectively, while Medicare Part C includes individuals in
managed care plans (whose claims we could not observe), and
Part D claims are those for prescription drugs. For the Women’s
Health Initiative study, institutional review board approval was
obtained at each clinical center and all participants were provided
written informed consent.
2.3. Outcome variable: screening mammograms
background
Screening mammograms were recommended every 1 to 2 years
by the USPSTF during the study period (2005–2010) for women
aged 40 and older (although revised guidelines at the end of
2009 increased the regular screening age from 40 to 50 and
concluded that there was insufﬁcient evidence around screenings
for women over 75).[6] Screening mammograms were included
in Medicare preventive service coverage, and were subject to co-
insurance (20% in absence of supplementary policy), but not to
deductibles.
2.4. Measuring screenings with claims data
We measured screening mammogram frequency using repeated
events survival analysis. Medicare Physician/Supplier Part B
Carrier claims (including outpatient physician services) contained
screening mammogram records (HCPCS/CPT Codes 76092,
77057, G0202). This objective method of measuring receipt of
screening mammograms reduces or eliminates recall bias, which
may otherwise be inﬂuenced by psychological attitudes. We used
a modiﬁed published algorithm[23] to recode screening mammo-
grams as diagnostic if they occurred within 9 months of a
previous mammogram, or after diagnosis of breast cancer. The
WHI-Medicare link has been successfully used to measure
utilization in prior work.[24]
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2.5. Predictor variables
Baseline optimism was assessed by the 6-item Life Orientation
Test-Revised (LOT-R),[11] with scores ranging from 6 to 30;
higher scores indicate greater optimism and lower scores indicate
greater pessimism. Women were classiﬁed by quartile of score in
the analysis sample, consistent with prior studies in the WHI:[8]
Least (<22), Mid-low (22 to <24), Mid-high (24 to <26),
Most (26+).
Baseline cynical hostility was assessed using the 13-item
cynicism subscale of the Cook Medley hostility questionnaire.
Scores range from 0 to 13, with higher scores indicating greater
cynicism.[25] Women were classiﬁed by quartile of score in the
analysis sample, consistent with prior studies:[8] Least (<1), Mid-
low (1 to <3), Mid-high (3 to <5), Most (5+).
2.6. Covariates and potential confounders
All survival models adjust for age on Jan 1, 2005 (continuous).
Subsequent models also adjust for the following covariates: OS or
CT (active hormone therapy, placebo arm, or not randomized
into hormone therapy, including Dietary Modiﬁcation trial
participants), and original Medicare eligibility (65+, disability,
end-stage renal disease). Factors capturing potential screening
barriers included lack of insurance at WHI baseline (which could
have preceded Medicare enrollment)[26] and having a regular
medical provider.[27] Depressive symptoms[28] and social sup-
port[29] were included for their association with cancer screen-
ings. Depressive symptoms were measured using the Burnam
Screening Algorithm,[30] a questionnaire that includes 6 items
from the Center for Epidemiologic Studies Depression Scale
(CES-D) and 2 items from the Diagnostic Interview Scale (DIS),
with a cutoff of ≥0.06 indicating depression.[30] The WHI social
support construct is a continuous measure using 9 items selected
from the Medical Outcomes Study).[31] Baseline health behaviors
associated with breast cancer screening or risk included alcohol
consumption,[32] exercise[33] (MET-hours/week <2.5, 2.5 to
<18.5, and 18.5 or greater), high cholesterol requiring pills
ever,[34] and family history of ﬁrst-degree female relatives with
breast cancer (none, or ≥1). Additional health factors associated
with screenings or cancer risk were updated through 2005 when
available: smoking status (current, past, or never smoker),[32]
obesity (BMI ≥ 30[35]), hypertension ever,[36] diabetes ever,[37]
and breast biopsies (0, 1, or ≥2). Family or personal history of
breast cancer or benign breast disease is associated with higher
mammography utilization.[32]
Models including sociodemographic variables additionally
adjust for race/ethnicity, education, and income as self-reported
at WHI baseline: race/ethnicity (White, Black, Hispanic/Latina,
Asian or Paciﬁc Islander, American Indian or Alaskan Native,
and Other which could include mixed race); education (less than
high school, high school or GED, some school past high school,
college or some post-graduate/post-professional training, and
graduate degree or higher); gross total family annual income
(reported incomes collapsed into 4 categories: <$20,000;
$20,000-$49,999; $50,000 to $74,999; and ≥$75,000).
2.7. Statistical methods
2.7.1. Descriptive methods. We described baseline sample
characteristics according to race/ethnicity, income, education,
mean optimism and cynical hostility scores, and covariates noted
above (n=48,291). We also described the distribution of mean
optimism and cynical hostility at various race/ethnicity, educa-
tion, and income levels, and tested for signiﬁcant associations
using chi-squared tests.
2.7.2. Longitudinal methods. Precise mammography screening
frequency was examined using multivariate repeated events
survival analyses, adjusted for relevant covariates, in 3 sets of
models using Cox proportional hazards models for conditional
risk set recurrent event data with a time scale measured in years
(PROC PHREG, SAS Version 9.3).[38] Variance of the
coefﬁcients was adjusted using the robust sandwich estimator
to address within-person correlation of events.
Include: Women enrolled in Medicare Parts 
A + B for 2 or more 
years from 2005-2010 and NOT 
ENROLLED IN PART C
(n =  55,413) 
Final Analysis Cohort (n=48,291)
Censor women at time of: 
1. Death
2. Breast cancer diagnosis
Number Censored Per 
Year
2005: 281
2006: 241
2007: 933
2008: 996
2009: 1117
2010: 1019
Exclude (Step 1) 
Women with missing data on 
Optimism or Cynical Hostilty at 
baseline 
(n=2,608, 4.7%))
Exclude (Step 2)
Women with a history of
breast cancer at baseline or 
missing breast cancer history
(n=2,190, 4.1% )
Exclude (Step 3)
Women who developed breast 
cancer over main study (through 
2005)
(n=2,324, 4.6%)
Figure 1. Flowchart of cohort creation. Notes: Censorship rates in 2005 and
2006 are lower because women were required to have at least 2 years of
Medicare claims starting in 2005, so censorship in these ﬁrst 2 years was due to
breast cancer diagnosis alone.
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Survival analyses model the “hazard” of a speciﬁc event
occurring over time (e.g., any number of days, weeks, years, etc).
Rather than specifying an interval over which an event may have
occurred (e.g., whether a woman received a mammogram in 2
years), these models account for the fact that the time intervals
until an event occurs will vary, and that this variation (1 year vs 5
years until an event occurs, for example) yields additional
important data. Cox proportional hazards regression models are
a class of regression models for this type of data which also allow
for covariate adjustment.
Survival models better characterize the frequency of screenings
over time and account for events which might alter normal
screening timelines, such as receipt of a diagnostic mammogram
without diagnosis of breast cancer (effectively extending the time
a woman could wait before additional screening). In our analysis,
each woman enters the risk set at a valid starting event, and is
assumed not to be at risk of a second event until her ﬁrst event is
complete, thus “resetting the clock.” Valid starting events
included: study start, screening mammogram, or a diagnostic
mammogram without breast cancer diagnosis. Screenings and/or
diagnoses that occurred within 8 weeks of each other were
considered part of the same event; therefore, if a woman had a
screening mammogram followed by diagnosis of breast cancer
within 8 weeks this would count as a screening “start point” and
a diagnosis “end point” (censoring following data) and the days
in between were excluded from analyses. Women were removed
from the risk set when the study period ended, or due to breast
cancer diagnosis or death (for examples of screening timelines,
see Fig. 2).
Model 1 examined the main effects of optimism and cynical
hostility as predictors for screenings (both attitudes modeled
together in a single model) after adjustment for age. Model 2
includes Model 1, and also adjusts for health- and healthcare
variables. In Model 3, variables for race/ethnicity, income, and
education were added to Model 2 to observe the extent to which
these variables mediated the association between attitudes and
screening frequency. We considered sociodemographic variables
to have a mediation-like effect if, when added, the attitude effects
Figure 2. Screening mammography timelines in survival models. Notes: the ﬁgure above provides examples of potential individual participant timelines and how
these timelines are interpreted for survival models. Intervals with diagonal lines are included in the analyses; those with dots are excluded from analyses because
they follow either death or a breast cancer diagnosis. Screening mammograms (designated with a black “X”) are considered events, and survival models assess
how the hazard for the event (screening mammogram) differs for women with, for example, least vs most optimism scores. A diagnosis of breast cancer or death
(both designated with a square) are terminal end points, meaning that the individual is no longer eligible for the event. “Censored” start and end points indicate that
the exact date of the previous or subsequent screeningmammogram (the event) is unknown, for example, at the beginning of the observation period, and at the end
of the study follow-up period. Diagnostic mammograms are considered deﬁnite start points (they re-set a woman’s clock for a potential new screening at that exact
time); however, they are considered censored end-points (they are not the screening event of interest, so they function similar to ending an eligible follow-up
window). In the ﬁgure above, Timeline A represents a woman with 2 screening mammograms during her follow up, and ends at the study end (censored end point).
Timelines B and C include diagnostic mammograms as well as screening mammograms. Timelines D and E show a case where follow-up is ended due to breast
cancer diagnosis (D) or death (E). Finally, Timeline F shows a case where a woman has no events during her entire follow-up period and until the study ends.
Progovac et al. Medicine (2019) 98:24 Medicine
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becamenon-signiﬁcant. Finally, a fourthmodel (Model 4) included
all variables in Model 3, plus the interaction between quartiles of
each attitude and whether women were age 75 or older during an
eligible screening interval that also occurred after January 1, 2009.
This model was added to account for the possibility that the
USPSTF guideline revisions at the end of 2009, which introduced
more uncertainty when screening women age 75 or older,
may drive differential patterns in mammography by age.
We considered P values less than .05 to be statistically
signiﬁcant.
3. Results
3.1. Descriptive characteristics
Overall, women had an average age of 72.2 (SD 6.4), were
primarily white (89.5%) and were relatively well-educated with
high-income: only 2.8% did not complete high school and 10.6%
reported household incomes under $20,000 annually (Table 1).
Women with no screenings vs any screening mammograms were
signiﬁcantly more likely to be older, racial/ethnic minorities, lower
SES, disabled, uninsured, and without a regular medical provider.
These women with no screenings were also more likely to be
current or past smokers, reported less exercise, and were less likely
to report any alcohol consumption. Women with no (vs any)
screenings also had slightly lower mean optimism scores (23.4 vs
23.6, P< .001, which matched the mean scores for the original
enrollment cohort) and slightly highermean cynical hostility scores
(3.7 vs 3.4, P< .001, which also matched means for the original
enrollment cohort). By contrast, women with any screening
mammograms (vs no screenings) reported higher social support.
Optimism quartile distributions by score were as follows: Least
(23%),Mid-Low (25%),Mid-High (24%),Most (28%).Hostility
quartile distributions by score were as follows: Least (15%), Mid-
Low (26%), Mid-High (27%), Most (31%). We did not ﬁnd
evidence that our Exclusion Steps or Censoring criteria impacted
the distribution of attitudes, compared to the enrollment cohort.
Mean optimism was generally lower for minority women
(except for black women, who resembled whites, Fig. 3). Mean
cynical hostility was higher for minority groups, with the
exception of Asian/Paciﬁc islander women. Optimism generally
increased with increased education and income, while the reverse
was true for cynical hostility. Differences were statistically
signiﬁcant by quartiles of optimism and cynical hostility
(chi-square tests, all P< .01).
3.2. Frequency of screening mammograms
Proportional hazards assumptions were satisﬁed for all survival
models (modeling until ﬁrst screening event), meaning that the
Table 1
Baseline characteristics and comparison of women with none vs any screening mammograms.
Characteristic (n,% unless
otherwise indicated)
All women
(N=48,291)
No screening
mammogram (N=6346)
Any screening
mammogram (N=41,945)
P value
(any vs no mamm.)
Enrolled in OS 26,079 54.0 3626 57.1 22,453 53.5 P< .001
Age on Jan 1, 2005 (Mean, SD) 72.2 6.4 74.1 7.4 71.9 6.2 P< .001
Region Northeast 12,354 25.6 1506 23.7 10,848 25.9
South 14,303 29.6 2051 32.3 12,252 29.2 P< .001
Midwest 11,434 23.7 1376 21.7 10,058 24.0
West 10,200 21.1 1413 22.3 8787 20.9
Race/ethnicity White 43,241 89.5 5617 88.5 37,624 89.7 P= .01
Black 27,46 5.7 384 6.1 2362 5.6
Hispanic 862 1.8 137 2.2 725 1.7
American Indian 128 0.3 25 0.4 103 0.2
Asian/Paciﬁc Islander 817 1.7 107 1.7 710 1.7
Other (Incl. Mixed Race and Unknown) 497 1.0 76 1.2 421 1.0
Education Less than high school 1380 2.8 277 4.4 1103 2.6 P< .001
High school diploma/GED 7840 16.2 1096 17.3 6744 16.1
School after high school 17,689 36.6 2493 39.3 15,196 36.2
College degree or some postgrad 11,834 24.5 1425 22.5 10,409 24.8
Graduate degree or higher 9324 19.3 1023 16.1 8301 19.8
Income <$20,000 5138 10.6 1102 17.4 4036 9.6 P< .001
$20,000–$49,999 19,881 41.2 2734 43.1 17,147 40.9
$50,000–$74,999 10,152 21.0 1099 17.3 9053 21.6
$75,000+ 10,443 21.6 1010 15.9 9433 22.5
Health system Uninsured 1414 2.9 307 4.8 1107 2.6 P< .001
No regular source of medical care 2498 5.2 578 9.1 1920 4.6 P< .001
Medicare eligibility 65+ 46,947 97.2 6109 96.3 40,838 97.4 P< .001
Disability 1332 2.8 235 3.7 1097 2.6
ESRD, or Disability + ESRD 12 0.0 2 0.0 10 0.0
Psycho-social Optimism construct (Mean, SD) 23.6 3.4 23.4 3.5 23.6 3.3 P< .001
Hostility construct (Mean, SD) 3.4 2.7 3.7 2.8 3.4 2.7 P< .001
Social support construct (Mean, SD) 36.6 7.4 35.7 8.0 36.8 7.3 P< .001
Health behaviors Consumed alcohol 34,193 70.8 4097 64.6 30,096 71.8 P< .001
Physical activity <2.5 METs/week 10,780 22.3 1710 27.0 9070 21.6 P< .001
2.5 – <18.25 METs/week 23,238 48.1 2977 46.9 20,261 48.3
≥18.25 METS/week 12,022 24.9 1399 22.1 10,623 25.3
Smoking Smoked at baseline of WHI 2674 5.5 509 8.0 2165 5.2 P< .001
Past smoker 20,534 42.5 2489 39.2 18,045 43.0
Never Smoked 24,605 51.0 3275 51.6 21,330 50.9
Health Obesity (BMI ≥ 30) 13,281 27.5 1929 30.4 11,352 27.1 P< .001
Hypertension ever 15,634 32.4 2264 35.7 13,370 31.9 P< .001
High cholesterol requiring pills ever 6346 13.1 845 13.3 5501 13.1 P= .82
Diabetes ever 2172 4.5 416 6.6 1756 4.2 P< .001
Depressive symptoms (CES-D) 4213 8.7 661 10.4 3552 8.5 P< .001
ESRD= end stage renal disease.
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hazard of screening for different levels of each independent
variable is proportional across the screening interval (e.g., level 1
vs 2 of a variable confers twice the risk of screening across the
entire screening interval)
In Model 1, which included each attitude plus adjustment for
age, optimism was not signiﬁcant (P= .10), while most (vs least)
cynically hostile women had 5% lower hazard of screening
(P< .01, Table 2).
In Model 2, which additionally adjusted for a host of health
and other covariates, least optimistic women had 4% more
frequent screenings compared to the most optimistic quartile of
women (P< .01, Table 2). Cynical hostility was not signiﬁcantly
associated with obtaining screening mammograms after these
additional covariate adjustments.
In Model 3, least vs most optimistic women had 5% more
frequent screening mammograms (P< .01), while cynical hostili-
ty remained non-signiﬁcant. Sociodemographic variables did not
appear to mediate the association between attitudes and
screening mammogram frequency, after adjusting for health
and healthcare related variables. The results for optimism and
cynical hostility, after adjustment for the health and other
covariates included in Model 2, remained robust to other model
speciﬁcations including: modeling attitudes as continuous
variables, modeling each attitude independently, and assessing
Figure 3. Distribution of attitudes by race/ethnicity and SES variables.
Table 2
Repeated events survival analysis of optimism, cynical hostility, race/ethnicity and socioeconomic status with screening mammograms
(robust variance estimator).
Model 1: attitudes + age
Model 2: Model 1 + health
and other covariates
Model 3 Model 2 + sociodemographic
variables
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Optimism (least vs most) 0.98 (0.96–1.00) 0.10 1.04 (1.02–1.06) <.01 1.05 (1.02–1.07) <.01
Cynical Hostility (most vs least) 0.95 (0.93–0.98) <0.01 1.00 (.97–1.02) .71 1.00 (.98–1.02) .91
Age (each additional year) 0.978 (0.977–0.980) <0.01 0.976 (0.975–0.977) <.01 0.976 (0.975–0.977) <.01
Health and other covariates
∗
Not included Adjusted for; HRs not reported here Adjusted for; HRs not reported here
Race/ ethnicity (Ref: white)
Black .97 (.94–1.00) .07
Hispanic .90 (.85-.95) <.01
American Indian or Alaskan Native .93 (.80–1.07) .31
Asian/Paciﬁc Islander 1.09 (1.03–1.15) <.01
Other/unknown .99 (.91–1.07) .72
Education (Grad degree + vs <HS) 1.07 (1.02–1.13) <.01
Income (≥$75K vs <$20 K annually) 1.10 (1.06–1.13) <.01
Ordinal categorical variables contrast highest and lowest categories only.
CI= conﬁdence interval; HR=hazard ratio, HS=high school.
∗
Health and other covariates include WHI cohort arm, Medicare eligibility, insurance status at WHI baseline, having a regular medical provider, depressive symptoms, social support, alcohol consumption, physical
activity, history of cholesterol medication, family history of ﬁrst-degree female relatives with breast cancer, smoking status, obesity, hypertension, diabetes, and history of breast biopsies.
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the constructs of optimism and pessimism individually via the
optimism and pessimism subscales.
In Model 3, several sociodemographic variables were signiﬁ-
cant independent predictors of mammogram screening frequen-
cy, even after adjusting for attitudes and for health and healthcare
related variables. The most educated women in the sample had
7% more frequent screenings than those without a high school
degree (P=<.01). Those women in the highest income bracket
(whose household earnings were at least $75,000 annually) had
10%more frequent screenings than those womenwith household
incomes under $25,000 annually (P< .01). Models indicated
signiﬁcant differences in screenings across racial/ethnic groups;
however, due to smaller sample sizes the individual group
estimates should be interpreted with caution. Compared to white
women (reference group), Hispanic women had 10% less
frequent screenings (P< .01), while Asian and Paciﬁc Islander
women had 9% more frequent screenings (P< .01).
In Model 4 (not shown), we found a signiﬁcant interaction
(overall interaction P value<.01) between optimism andwhether
a woman was age 75 or older during an eligible screening interval
that also occurred after January 1, 2009 (the year of the USPSTF
policy change). This interaction showed that overall model results
were driven primarily by women who were 75 or older during
eligible screening intervals (HR: 1.05, 95% CI 1.03–1.08),
whereas women who had not turned 75 during their eligible
screening intervals did not show a signiﬁcant effect of optimism
(HR 0.99, 95% CI 0.95–1.03). We did not ﬁnd a signiﬁcant
interaction between cynical hostility and this age cutoff (P= .71).
4. Discussion
Contrary to our hypotheses, repeated events survival models
showed that after adjusting for age as well as health and other
covariates, women with the lowest optimism scores (i.e., women
with more pessimistic tendencies) received 5% more frequent
screenings than those in the most optimistic group. Also contrary
to our hypotheses, there was no association between cynical
hostility and frequency of screeningmammograms after adjusting
for age as well as health and other covariates. However,
consistent with expectations and with past literature,[10] higher
income, education, and identifying as an Asian/Paciﬁc Islander
was associated with higher screening frequency, while identifying
as Hispanic/Latina was associated with lower screening frequen-
cy. Finally, we found that results for optimism were primarily
driven by women who were 75 or older during an eligible
screening interval that also occurred after January 1, 2009.
Our results for least optimistic women receiving more frequent
screenings were surprising, based on a large body of literature
demonstrating that more optimistic women tend to be healthier
and adhere to medical advice more readily than less-optimistic
peers,[16,18] and would therefore be expected to undergo
screening at higher rates. One explanation for the fact that we
see differences between the simplest models and those adjusted
for other covariates beyond age is that we have adjusted for
factors which may operate to increase the likelihood of screening
in the presence of higher trait optimism, including patterns of
healthier behaviors (less smoking, more physical activity) and
overall better physical health (lower average BMI, less hyperten-
sion, less diabetes) and mental health (fewer depressive
symptoms). With greater consideration, these ﬁndings make
sense based on a literature demonstrating that people with
pessimistic tendencies use more primary care physician visits,
specialty care, and hospital treatment.[39] Having more exposure
to the health systemmay increase the opportunity for screening to
be recommended or at least discussed by health care providers.
Our work also adds directly to existing literature by rigorously
measuring preventive mammography utilization over time using
repeated events survival analysis, rather than simply assessing
whether or not any screenings occurred, and by using claims data
instead of self-report, thus reducing potential validity threats
based on differential recall.
We found signiﬁcant associations between screenings and
income, education, and race/ethnicity. These factors may capture
barriers to receipt of screenings, but may also capture cultural
differences in perceived risks and beneﬁts of screenings: for
example, some studies document lower perceived beneﬁt of
mammography among Hispanic/Latina women who do not have
any symptoms of breast cancer.[40] The current study is not
designed to capture such differences in perceptions of risks and
beneﬁts, which may vary by race/ethnicity, cultural factors, and
medical practice patterns in one’s community or country of
origin. However, these factors could supersede health insurance,
income, and other factors in driving screening behaviors. There
may be additional factors not captured in this analysis that could
disproportionately hinder Hispanic/Latina women, or enable
Asian/Paciﬁc Islander women, when it comes to screening
mammography.
We found that older optimists (i.e., those facing uncertainty
about risks and beneﬁts of screening after the change to the
USPSTF recommendations) were less likely to receive screening
mammograms. Changes to screening recommendations likely
increase uncertainty and anxiety around the risks and beneﬁts of
screenings for both patients and providers, and patients’
dispositional attitudes about the future are likely to inﬂuence
how they manage this uncertainty. This underscores the
importance of comprehensive shared decision making conversa-
tions with providers, especially given that studies have shown
providers most often discuss beneﬁts of screenings, but do not
routinely address screening risk or ask patients about their
screening preferences.[41] This may be in part because those rare
clinical practice guidelines that do advise shared decision-making
often “provide no guidance about how to do this and
communicate the evidence in a way patients will understand”.[42]
5. Limitations
Despite the strengths of this analysis, it has several important
limitations. WHI women were typically healthier than post-
menopausal woman on average in the U.S. Only baseline
measurements of optimism and cynical hostility were used, and
although they are considered relatively stable traits, they can
change over time[43] or in the presence of targeted interven-
tions.[44,45] This analysis could not observe women’s utilization
inMedicare part C (and these women were thus excluded), or the
presence of supplemental coverage (Medigap) plans which are
more likely to be purchased by higher SES women and which
could lower costs for individual screenings. Our identiﬁcation of
women eligible for screening mammograms based on available
health and demographic characteristics may under or over-
estimate eligibility especially if health conditions are miscoded.
This study was not designed to observe the content of patient-
provider interactions which preceded screening mammograms.
The WHI also does not measure individuals’ perception
regarding breast or other cancer risk, which may be inaccurate.
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For example, underestimation of true objective risk is termed the
“optimistic bias”, which is distinct from, but often confused with,
dispositional optimism.[46,47] In studies that have measured both
dispositional optimism and optimistic bias (unrealistic opti-
mism), dispositional optimists tend to have accurate perceptions
of their health risks and beneﬁts (i.e., they do not have a so-called
optimistic bias).[48] Therefore, underestimation of breast cancer
risk is unlikely to explain the observed lower rates of
mammography screening among women with higher levels of
dispositional optimism. Additionally, it would be difﬁcult to
generalize these results to other screening behaviors in men or to
other types of screenings.
6. Conclusions and policy implications
Lower optimism, higher education, and higher income all
predicted more frequent screening mammograms in this sample
after repeated events survival modeling and covariate adjustment.
Guidelines for screening mammography which place increased
decision-making burden on an individual’s perception of risk
may result in women with certain attitudinal traits being more or
less likely to receive screenings. Physicians should proceed
cautiously when applying new and evolving guidelines which
place increased decision-making burden on a woman’s individual
perceptions of risk and belief that good or bad things may happen
to her. More work is needed to determine whether these
differences may inﬂuence over- or under-screening for certain
groups of women. Comprehensive shared decision-making for
screeningmammograms in the face of uncertainty about risks and
beneﬁts should help ensure that women are making fully
informed decisions, regardless of dispositional attitude or prior
perceptions of risk.
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